Attached files

file filename
EX-21 - SUBSIDIARIES OF THE REGISTRANT - GlobeStar Therapeutics Corpex_21.htm
EXCEL - IDEA: XBRL DOCUMENT - GlobeStar Therapeutics CorpFinancial_Report.xls
10-Q - FORM 10-Q QUARTERLY REPORT FOR 12-31-2014 - GlobeStar Therapeutics Corpform_10-q.htm
EX-31 - RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION - GlobeStar Therapeutics Corpex_31-1.htm

Exhibit 32.1


SECTION 1350 CERTIFICATION


In connection with the quarterly report of First Titan Corp. (the “Company”) on Form 10-Q for the period ended December 31, 2014 as filed with the Securities and Exchange Commission (the “Report”), I, Sydney Jim, President of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Date: February 17, 2015

BY: /s/ Sydney Jim

 

Sydney Jim

 

Chief Executive Officer, President, Secretary, Treasurer, Principal Executive Officer, Principal Finance and Accounting Officer and Sole Director


A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.